Given the distinct immune-regulatory functions of the AXL+ monocyte population in patients with cirrhosis and its association with disease severity and infection, we questioned whether inhibition or down-regulation of AXL would reverse the anti-inflammatory properties. The gene discussed is AXL; the disease is Cirrhosis.